Latest news
Loading news…
Keymed Biosciences
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Chengdu, Sichuan, China Founded 2016 1001-5000 employees For Profit
Keymed Biosciences develops innovative monoclonal antibody drugs and other therapeutic protein drugs for major diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Ticker
2162
HKG - Hong Kong Stock Exchange
Patents
11
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- 2162
- Exchange
- HKG - Hong Kong Stock Exchange
- IPO date
- Jul 9, 2021
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 11
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2016
- Employees
- 1001-5000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 81
- HQ
- Chengdu, Sichuan, China
- Region
- Asia-Pacific (APAC)
- Exit date
- Jul 9, 2021
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 2.7
- Trend (30d)
- 1.7
- Trend (90d)
- -0.6
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Keymed Biosciences
Loading news…
FAQs about Keymed Biosciences
People who checked this page also checked these
Browse the full Acquirezy directory.